Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) FCF Margin (2022 - 2025)

Historic FCF Margin for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to 18.79%.

  • Indivior Pharmaceuticals' FCF Margin fell 171600.0% to 18.79% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.08%, marking a year-over-year increase of 329100.0%. This contributed to the annual value of 0.59% for FY2024, which is 287700.0% up from last year.
  • As of Q3 2025, Indivior Pharmaceuticals' FCF Margin stood at 18.79%, which was down 171600.0% from 46.69% recorded in Q2 2025.
  • In the past 5 years, Indivior Pharmaceuticals' FCF Margin registered a high of 46.69% during Q2 2025, and its lowest value of 105.8% during Q4 2023.
  • Moreover, its 4-year median value for FCF Margin was 3.26% (2023), whereas its average is 3.68%.
  • In the last 5 years, Indivior Pharmaceuticals' FCF Margin tumbled by -946000bps in 2023 and then skyrocketed by 947300bps in 2024.
  • Over the past 4 years, Indivior Pharmaceuticals' FCF Margin (Quarter) stood at 11.2% in 2022, then tumbled by -844bps to 105.8% in 2023, then surged by 90bps to 11.07% in 2024, then plummeted by -70bps to 18.79% in 2025.
  • Its FCF Margin stands at 18.79% for Q3 2025, versus 46.69% for Q2 2025 and 26.32% for Q1 2025.